Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy

SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more rapidly than the wild-type virus. Because the molecular biology of this virus has been studied in such great detail, it represents an archetypal paradigm for research into new antiviral drug therapies. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridgway, Harry, Chasapis, Christos T., Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J., Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Mavromoustakos, Thomas, Matsoukas, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143829/
https://www.ncbi.nlm.nih.gov/pubmed/35632769
http://dx.doi.org/10.3390/v14051029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143829/
https://www.ncbi.nlm.nih.gov/pubmed/35632769
http://dx.doi.org/10.3390/v14051029

Ejemplares similares